Kiniksa Pharmaceuticals International, plc Annual Net Income (Loss) Attributable to Parent in USD from 2017 to 2023

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kiniksa Pharmaceuticals International, plc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2017 to 2023.
  • Kiniksa Pharmaceuticals International, plc Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$3.91M, a 126% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$10.2M, a 104% decline year-over-year.
  • Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2023 was $14.1M, a 92.3% decline from 2022.
  • Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2022 was $183M.
  • Kiniksa Pharmaceuticals International, plc annual Net Income (Loss) Attributable to Parent for 2021 was -$158M, a 2.14% increase from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $14.1M -$169M -92.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-28
2022 $183M +$341M Jan 1, 2022 Dec 31, 2022 10-K 2024-02-28
2021 -$158M +$3.46M +2.14% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-28
2020 -$161M +$486K +0.3% Jan 1, 2020 Dec 31, 2020 10-K 2023-03-02
2019 -$162M -$58.6M -56.8% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-24
2018 -$103M -$38.4M -59.1% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-25
2017 -$64.9M Jan 1, 2017 Dec 31, 2017 10-K 2019-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.